Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.
Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D, Walter E, Watson B, Krah DL, Dallas MJ, Schödel F, Kaplan kM, Heaton P.
Clark HF, et al.
Pediatr Infect Dis J. 2003 Oct;22(10):914-20. doi: 10.1097/01.inf.0000091887.48999.77.
Pediatr Infect Dis J. 2003.
PMID: 14551493
Clinical Trial.